Perceptive Informatics Enhances CNS and Oncology Medical Image Processing and Analysis Capabilities Through Alliance With B...(d on improving the productivity and effi...),Health

According to Barry J. Bedell, M.D., Ph.D., Chief Operating Officer and Chief Science Officer, Biospective, "We are pleased to work closely with Perceptive to provide clinical study sponsors with high medical image quality as well as advanced image processing and analysis capabilities for early- and late-phase CNS and oncology trials."

Biospective supplements the medical imaging capabilities of Perceptive Informatics by providing software solutions tailored for CNS and oncology studies, including specialized Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) techniques. The Medical Imaging Group of Perceptive Informatics offers a range of capabilities in the application of imaging techniques from early clinical development through peri-approval studies. The medical imaging team operates globally and services a wide range of therapeutic areas, including oncology, central nervous system, musculoskeletal, cardiovascular, and metabolism/endocrinology imaging.

About Perceptive Informatics

Perceptive Informatics, a leading eClinical solutions provider and subsidiary of PAREXEL, is focused on helping customers to accelerate the product development process through innovation. The Perceptive Informatics industry-leading eClinical product portfolio is built on advanced technology that benefits from extensive medical and clinical expertise as well as a deep understanding of the regulatory environment. The portfolio includes Randomization and Trial Supply Management (RTSM) technologies, Medical Imaging, Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), and Electronic Patient-Reported Outcomes (ePRO). For more information about the integrated solutions in Perceptive's eClinical Suite visit: www.perceptive.com.

About PAREXEL
'/>"/>